Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03987789
Other study ID # IMPROVE-2 study
Secondary ID 2019-A00265-52
Status Completed
Phase N/A
First received
Last updated
Start date February 18, 2021
Est. completion date October 27, 2022

Study information

Verified date July 2022
Source University Hospital, Clermont-Ferrand
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to compare the effects of a strategy aimed at increasing alveolar recruitment (high PEEP levels adjusted according to driving pressure and recruitment maneuvers) with that of a strategy aimed at minimizing alveolar distension (low PEEP level without recruitment maneuver) on postoperative respiratory failure and mortality in patients receiving low VT ventilation during emergency abdominal surgery.


Description:

Emergency abdominal surgery is associated with a high risk of morbidity and mortality. Postoperative pulmonary complications (PPCs) are the second most common surgical complication and adversely influence surgical morbidity. Postoperative respiratory failure (PRF) is one of the most serious pulmonary complication. Two hypotheses can be forward by the literature. First, a low VT lung protective ventilation in combination with a strategy aimed at minimizing alveolar distension by using low PEEP level (and without recruitment maneuver) could improve postoperative outcome while reducing the risk of hemodynamic alterations or, second, could increase the risk of PRF compared with a strategy aimed at increasing alveolar recruitment using higher PEEP level adjusted according to driving pressure in combination with recruitment maneuvers in adult patients undergoing emergency abdominal surgery. Given the uncertainties, and in order to determine the impact of lung protective ventilation strategies on clinical outcomes of high-risk surgical patients, a randomized trial is needed. Our primary hypothesis is that, during low VT ventilation, a strategy aimed at increasing alveolar recruitment by using high PEEP levels adjusted according to driving pressure in combination with recruitment maneuvers could be more effective at reducing PRF and mortality after emergency abdominal surgery than a strategy aimed at minimizing alveolar distension by using lower PEEP without recruitment maneuver. Given the number of patients for whom the question applies, the prevalence and the burden of PPCs, the study can have significant clinical importance and public health implications.


Recruitment information / eligibility

Status Completed
Enrollment 707
Est. completion date October 27, 2022
Est. primary completion date July 29, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult (=18 years) - Patients requiring emergency (defined by the need to proceed to surgery within a few hours after diagnosis) - Laparoscopic or non-laparoscopic abdominal surgery under general anesthesia and with an expected duration of at least two hours Exclusion Criteria: - Patients already receiving mechanical ventilation for more than 12 hours before enrollment - Intracranial hypertension - Chronic respiratory disease requiring oxygen therapy or mechanical ventilation at home - Undrained pneumothorax or subcutaneous emphysema - Patients for which death is deemed imminent and inevitable or patients with an underlying disease process with a life expectancy of less than 3 month - Body mass index (BMI) >40 kg/m2 - Pregnant or breastfeeding women - Patients already enrolled in the IMPROVE-2 trial - Participation in a confounding trial with mortality or PRF as the main endpoint - Patient's or relative's refusal to participate - Guardianship or trusteeship patient - No affiliation to the Social Security system

Study Design


Intervention

Other:
Driving-pressure-guided group
Patients will receive PEEP levels individually set at the highest possible value (up to 15 cmH2O) providing a driving pressure (airway plateau pressure minus PEEP) lower than 13 cmH2O, in addition to recruitment maneuvers.
Low PEEP
Patients will receive a PEEP level =5 cmH2O without recruitment maneuvers

Locations

Country Name City State
France University hospital Angers
France Hospital Annecy
France University hospital Besancon
France University Hospital Bordeaux
France Hospital Chalon-sur-Saône
France University hospital Clermont-Ferrand
France University hospital Dijon
France University hospital Grenoble
France University hospital Le Mans
France University hospital Lille
France University hospital Lyon
France University hospital Marseile
France Assistance Publique-Hôpitaux de Marseille Marseille
France Institut Paoli Calmette Marseille
France University hospital Marseille
France University hospital Montpellier
France University Hospital Nantes
France University hospital Nice
France University hospital Nîmes
France Assistance Publique-Hôpitaux de Paris Paris
France Hospital Périgueux
France University hospital Point A Pitre
France University hospital Rennes
France University hospital Saint-Etienne
France University hospital Strasbourg
France Hospital Suresnes
France University hospital Toulouse
France Hospital Valenciennes

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Postoperative respiratory failure Composite criteria :
- Failure to wean from the ventilator after surgery (Yes or No)
- Requiring unplanned reintubation (Yes or No)
- Curative non-invasive ventilation once extubated postoperatively (Yes or No)
- Death (all cause of mortality) (Yes or No)
If at least one of these 4 criteria is answered yes, the composite criterion (i.e. the primary outcome) will be answered yes
Hospital discharge - Up to day 30
Secondary Postoperative pulmonary complications Hypoxemia, pneumonia? development of acute respiratory distress syndrome (ARDS) Day 30
Secondary Postoperative extra-pulmonary complications sepsis and septic shock, renal dysfunction Day 30
Secondary SOFA Sequential-related Organ Failure Assessment Day 1
Secondary SOFA Sequential-related Organ Failure Assessment Day 2
Secondary SOFA Sequential-related Organ Failure Assessment Day 3
Secondary SOFA Sequential-related Organ Failure Assessment Day 4
Secondary SOFA Sequential-related Organ Failure Assessment Day 5
Secondary SOFA Sequential-related Organ Failure Assessment Day 6
Secondary SOFA Sequential-related Organ Failure Assessment Day 7
Secondary Ventilator-free days The number of days alive and with unassisted breathing Day 30
Secondary Duration of invasive mechanical ventilation Duration of invasive mechanical ventilation from randomization to first tracheal extubation Up to Day 30
Secondary Total duration of mechanical ventilation Total duration of mechanical ventilation (additive, for all épisodes) Up to Day 30
Secondary Time to successful tracheal extubation Absence of ventilatory support during the first 48 hours after extubation 48 hours
Secondary Total volume of intraoperative fluids Total volume of intraoperative fluids (crystalloids and colloids) Day 1
Secondary Median norepinephrine doses during surgery µg/kg/min Day 1
Secondary Median phenylephrine doses during surgery µg/kg/min Day 1
Secondary Median ephedrine doses during surgery µg/kg/min Day 1
Secondary Intensive care unit (ICU)-free days Intensive care unit (ICU)-free days Day 30
Secondary Duration of ICU stay Duration of ICU stay Up to day 90
Secondary Duration of hospital stay Duration of hospital stay Up to day 90
Secondary All-cause mortality All-cause mortality Day 30
Secondary All-cause mortality All-cause mortality Day 90
Secondary Time to death Time to death (Days) Up to 90 days
Secondary Hemodynamic instability Hemodynamic instability ventilatory-related defined as a drop of arterial systolic pressure below 80 mmHg for more than 5 minutes not responding to treatment Up to day 30
Secondary Pneumothorax Pneumothorax ventilatory-related Up to day 30
See also
  Status Clinical Trial Phase
Completed NCT05921656 - Construction and Evaluation of Airway Leakage Risk Model of Patients With Endotracheal Tube
Recruiting NCT03941002 - Continuous Evaluation of Diaphragm Function N/A
Withdrawn NCT04288076 - The Brain and Lung Interaction (BALI) Study N/A
Completed NCT03031860 - Semi-quantitative Cough Strength Score (SCSS) N/A
Completed NCT02545621 - A Role for RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation During ARDS (RIAMA): a Proof-of-concept Clinical Study
Completed NCT02312869 - Local Assessment of Management of Burn Patients N/A
Completed NCT01885442 - TryCYCLE: A Pilot Study of Early In-bed Leg Cycle Ergometry in Mechanically Ventilated Patients N/A
Completed NCT01204281 - Proportional Assist Ventilation (PAV) in Early Stage of Critically Ill Patients Phase 4
Terminated NCT01059929 - Dexmedetomidine Versus Propofol in the Medical Intensive Care Unit (MICU) Phase 4
Completed NCT00824239 - Intermittent Sedation Versus Daily Interruption of Sedation in Mechanically Ventilated Patients Phase 3
Completed NCT00529347 - Mechanical Ventilation Controlled by the Electrical Activity of the Patient's Diaphragm - Effects of Changes in Ventilator Parameters on Breathing Pattern Phase 1
Unknown status NCT00260676 - Protective Ventilatory Strategy in Potential Organ Donors Phase 3
Terminated NCT00205517 - Sedation and Psychopharmacology in Critical Care N/A
Completed NCT03281785 - Ultrasound of Diaphragmatic Musculature in Mechanically Ventilated Patients. N/A
Recruiting NCT04110613 - RCT: Early Feeding After PEG Placement N/A
Completed NCT04410783 - The Emergency Department Sedation Pilot Trial N/A
Recruiting NCT04821453 - NAVA vs. CMV Crossover in Severe BPD N/A
Completed NCT03930147 - Ventilation With ASV Mode in Children N/A
Recruiting NCT05029167 - REstrictive Versus LIberal Oxygen Strategy and Its Effect on Pulmonary Hypertension After Out-of-hospital Cardiac Arrest (RELIEPH-study) N/A
Recruiting NCT04849039 - Lung Microbiota and VAP Development (PULMIVAP)